Pages that link to "Q74330354"
Jump to navigation
Jump to search
The following pages link to Cross-presentation of tumor antigens by bone marrow-derived antigen-presenting cells is the dominant mechanism in the induction of T-cell tolerance during B-cell lymphoma progression (Q74330354):
Displayed 50 items.
- CD70+ non-Hodgkin lymphoma B cells induce Foxp3 expression and regulatory function in intratumoral CD4+CD25 T cells (Q24681974) (← links)
- Myeloid suppressor cells and immune modulation in lung cancer (Q26823251) (← links)
- Impaired T-Cell Function in B-Cell Lymphoma: A Direct Consequence of Events at the Immunological Synapse? (Q27003955) (← links)
- Myeloid suppressor cell depletion augments antitumor activity in lung cancer (Q28729158) (← links)
- IDO expression by dendritic cells: tolerance and tryptophan catabolism (Q29614752) (← links)
- Immunosuppressive strategies that are mediated by tumor cells (Q29636247) (← links)
- Low-Intensity Focused Ultrasound Induces Reversal of Tumor-Induced T Cell Tolerance and Prevents Immune Escape. (Q30363260) (← links)
- Role of CXCR3 ligands in IL-7/IL-7R alpha-Fc-mediated antitumor activity in lung cancer (Q30426606) (← links)
- B7+ T cells in myeloma: an acquired marker of prior chronic antigen presentation (Q33202103) (← links)
- Antibody-mediated B-cell depletion before adoptive immunotherapy with T cells expressing CD20-specific chimeric T-cell receptors facilitates eradication of leukemia in immunocompetent mice (Q33560416) (← links)
- Immune checkpoint blockade for hematologic malignancies: a review (Q33645590) (← links)
- Mechanism of T cell tolerance induced by myeloid-derived suppressor cells. (Q33705930) (← links)
- Intratumoral convergence of the TCR repertoires of effector and Foxp3+ CD4+ T cells (Q33737660) (← links)
- In vivo cyclophosphamide and IL-2 treatment impedes self-antigen-induced effector CD4 cell tolerization: implications for adoptive immunotherapy (Q33756565) (← links)
- Effector CD4 cells are tolerized upon exposure to parenchymal self-antigen (Q33791198) (← links)
- Peripheral Tolerization of Effector and Memory T Cells: Implications for Autoimmunity and Tumor-Immunity (Q33801059) (← links)
- Towards a genetic definition of cancer-associated inflammation: role of the IDO pathway (Q33816244) (← links)
- Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance (Q33897693) (← links)
- Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells (Q33919954) (← links)
- CD40 stimulation leads to effective therapy of CD40(-) tumors through induction of strong systemic cytotoxic T lymphocyte immunity (Q34025520) (← links)
- Tumor cells engineered to codisplay on their surface 4-1BBL and LIGHT costimulatory proteins as a novel vaccine approach for cancer immunotherapy (Q34137777) (← links)
- T cells from the tumor microenvironment of patients with progressive myeloma can generate strong, tumor-specific cytolytic responses to autologous, tumor-loaded dendritic cells (Q34191186) (← links)
- Tumor-associated CD8+ T cell tolerance induced by bone marrow-derived immature myeloid cells (Q34312635) (← links)
- Non-hematopoietic expression of IDO is integrally required for inflammatory tumor promotion (Q34393455) (← links)
- How Do CD4(+) T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules? (Q34418112) (← links)
- A CpG-loaded tumor cell vaccine induces antitumor CD4+ T cells that are effective in adoptive therapy for large and established tumors (Q34568823) (← links)
- Combinations of immunotherapy and radiation in cancer therapy. (Q34582640) (← links)
- FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer (Q34755205) (← links)
- Immunotherapy with acute leukemia cells modified into antigen-presenting cells: ex vivo culture and gene transfer methods (Q34926682) (← links)
- Cytokine modified tumor vaccines (Q35027823) (← links)
- Dendritic cell-mediated immunization in macroglobulinemia (Q35116896) (← links)
- Dendritic cell regulation of immune responses: a new role for interleukin 2 at the intersection of innate and adaptive immunity (Q35139530) (← links)
- Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy (Q35177556) (← links)
- Stereotactic Radiation Therapy Augments Antigen-Specific PD-1-Mediated Antitumor Immune Responses via Cross-Presentation of Tumor Antigen (Q35328111) (← links)
- Ubiquitinated proteins enriched from tumor cells by a ubiquitin binding protein Vx3(A7) as a potent cancer vaccine (Q35519862) (← links)
- T-helper cell tolerance to ubiquitous nuclear antigens (Q35589560) (← links)
- Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. (Q35835489) (← links)
- In vivo disruption of tolerogenic cross-presentation mechanisms uncovers an effective T-cell activation by B-cell lymphomas leading to antitumor immunity (Q35848586) (← links)
- Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines (Q35849310) (← links)
- Marginating dendritic cells of the tumor microenvironment cross-present tumor antigens and stably engage tumor-specific T cells (Q35851748) (← links)
- NFAT1 supports tumor-induced anergy of CD4(+) T cells (Q36243594) (← links)
- Reciprocal changes in tumor antigenicity and antigen-specific T cell function during tumor progression (Q36399807) (← links)
- An epigenetic vaccine model active in the prevention and treatment of melanoma (Q36440002) (← links)
- CD40 ligation reverses T cell tolerance in acute myeloid leukemia (Q36793408) (← links)
- Indoleamine 2,3-dioxygenase and tumor-induced tolerance (Q36809762) (← links)
- Defective MHC class II presentation by dendritic cells limits CD4 T cell help for antitumor CD8 T cell responses (Q36983599) (← links)
- Enhancing the safety of antibody-based immunomodulatory cancer therapy without compromising therapeutic benefit: Can we have our cake and eat it too? (Q37114367) (← links)
- Attenuation of CD8(+) T-cell function by CD4(+)CD25(+) regulatory T cells in B-cell non-Hodgkin's lymphoma (Q37188161) (← links)
- Immunotherapy for myeloid leukemias: current status and future directions (Q37194498) (← links)
- Mast cells as regulators of adaptive immunity to tumours. (Q37348856) (← links)